Comparable to the 2020 resolution, Novartis AG’s $25 million 2016 civil resolution Along with the SEC anxious poor sponsorships of HCPs to conferences and poor payments to HCPs to collect “health care facts.” The point that Novartis has become facing a significantly greater—and prison—resolution for related misconduct really should mail a